Literature DB >> 9511479

The effect of the subspinal Le Fort I-type osteotomy on interalar rim width.

M Y Mommaerts1, J V Abeloos, C A De Clercq, L F Neyt.   

Abstract

The postoperative increase in interalar rim width was measured in two groups undergoing Le Fort I impaction or advancement. In the control group, 19 patients with a conventional osteotomy, an absorbable alar cinch suture, and V-Y closure were followed for 20 months on average. In the experimental group, 12 patients with a "subspinal" Le Fort I osteotomy (without alar cinch or V-Y closure) were followed for 15 months on average. Interalar rim width was measured with a slide gauge preoperatively, at several times during surgery, and at the 6-month and late follow-up appointments. At surgery, the alar cinch suture decreased the interalar rim width by 50% in the control group. Still, after extubation, there was no statistical difference between groups. At the 6-month follow-up measurement, the interalar rim width was significantly (1.92 mm) smaller in the subspinal group. At the late follow-up, this difference had decreased by a mean of 0.61 mm.

Entities:  

Mesh:

Year:  1997        PMID: 9511479

Source DB:  PubMed          Journal:  Int J Adult Orthodon Orthognath Surg        ISSN: 0742-1931


  3 in total

1.  W-Shaped Osteotomy to Avoid Paranasal Deformity After Standard Le Fort I in Orthognathic Surgery.

Authors:  Mario Santagata; Nicola Sgaramella; Fabrizio Chirico; Salvatore D'Amato; Ivo Ferrieri; Giovanni Corvo; Camilla Corvo; Gianpaolo Tartaro
Journal:  Plast Surg (Oakv)       Date:  2020-11-10       Impact factor: 0.947

Review 2.  Review of nasal changes with maxillary orthognathic surgery.

Authors:  Leila Khamashta-Ledezma; Farhad B Naini; Mehmet Manisali
Journal:  J Istanb Univ Fac Dent       Date:  2017-12-02

3.  Facial soft tissue changes after maxillary impaction and mandibular advancement in high angle class II cases.

Authors:  Barış Aydil; Nedim Özer; Gülnaz Marşan
Journal:  Int J Med Sci       Date:  2012-06-09       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.